← All diseases
Cancer
Multiple myeloma
Do you want to receive a message when there is new research about Multiple myeloma? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication appears one sentence explaining what was investigated — and you receive a notification as soon as there is new research about Multiple myeloma. View what Premium costs.
Publications and studies (2183)
- A Polyherbal Ashwagandha Formulation Exhibits Adjunctive Antitumor Efficacy Against U266 Myeloma Cells by Multi-Strategic Cytotoxic Effects: An Experimental Approach. (2023/11/01) ♡
- Non-Toxicological Role of Aryl Hydrocarbon Receptor in Obesity-Associated Multiple Myeloma Cell Growth and Survival. (2023/11/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. An interesting case of systemic lupus erythematosus with multiple myeloma. (2023/11/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. [Characterization of patients with Philadelphia negative myeloproliferative neoplasms and concomitant monoclonal gammopathies: Just coincidence?]. (2023/11/01) ♡
- Complete blood and urine paraprotein tests as response assessments in multiple myeloma patients treated with bortezomib, cyclophosphamide, and dexamethasone. (2023/10/31) ♡
- Evaluation of acupuncture and auriculotherapy in the control of chemotherapy-induced nausea and vomiting: a Pilot Study. (2023/10/30) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Impacting T-cell fitness in multiple myeloma: potential roles for selinexor and XPO1 inhibitors. (2023/10/26) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Exploiting the potential of the ubiquitin-proteasome system in overcoming tyrosine kinase inhibitor resistance in chronic myeloid leukemia. (2023/10/26) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. First use of (18)F-FDG PET in TEMPI syndrome: can it be used for treatment assessment? A case report. (2023/10/26) ♡
- D-dimer predicts venous thromboembolism in multiple myeloma: a nested case-control study. (2023/10/19) ♡
- High NEK2 expression in myeloid progenitors suppresses T cell immunity in multiple myeloma. (2023/10/17) ♡
- [Alteration and significance of serum lipid levels and nutritional status during BCMA-CAR-T-cell therapy in patients with refractory or relapsed multiple myeloma: a retrospective study based on LEGEND-2]. (2023/10/14) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Nonrestrictive diet does not increase infections during post-HSCT neutropenia: data from a multicenter randomized trial. (2023/10/10) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Mediterranean diet and olive oil, microbiota, and obesity-related cancers. From mechanisms to prevention. (2023/10/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Gastrointestinal hemorrhage as an uncommon form of presentation of primary intestinal amyloidosis: case report]. (2023/10/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Bortezomib-based induction therapy followed by autologous hematopoietic cell transplantation in newly diagnosed multiple myeloma patients: A single-center experience and review of Indian literature. (2023/10/01) ♡
- MCQs on Bortezomib-based induction therapy followed by autologous hematopoietic cell transplantation in newly diagnosed multiple myeloma patients: A single-center experience and review of Indian literature. (2023/10/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Lesions of the spinal cord caused by multiple myeloma: A systematic review and meta-analysis regarding the neurosurgical aspects of patient management. (2023/10/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Chronic Inflammatory Demyelinating Polyradiculoneuropathy as a Presentation of Plasmacytoma. (2023/10/01) ♡
- Serendipitous Diagnosis of Tertiary Hyperparathyroidism in a Case Purportedly thought to have Skeletal Metastases. (2023/10/01) ♡
- Diagnostic Significance Of Bone Marrow Examination Amongst The Patients With Abnormal Haematological Parameters. (2023/10/01) ♡
- Nutritional Status Indices and Monoclonal Gammopathy of Undetermined Significance Risk in the Elderly Population: Findings from the National Health and Nutrition Examination Survey. (2023/09/29) ♡
- Pre-Diagnosis Dietary Patterns and Risk of Multiple Myeloma in the NIH-AARP Diet and Health Study. (2023/09/23) ♡
- A new autophagy-related nomogram and mechanism in multiple myeloma. (2023/09/21) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Recent advances in the treatment and prevention of peripheral neuropathy after multiple myeloma treatment. (2023/09/06) ♡
- Association of serum 25-hydroxyvitamin D with the incidence of 16 cancers, cancer mortality, and all-cause mortality among individuals with metabolic syndrome: a prospective cohort study. (2023/09/01) ♡
- Impact of 1q gains on treatment outcomes of patients with newly diagnosed multiple myeloma in a real-world Swedish population receiving modern treatment. (2023/09/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Therapeutic effect of trace elements on multiple myeloma and mechanisms of cancer process. (2023/09/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Prevalence and clinical outcomes of vitamin D deficiency among Japanese multiple myeloma patients: a single-center observational study. (2023/09/01) ♡
- Outcome of Second Primary Malignancies Developing in Multiple Myeloma Patients. (2023/09/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Role of the gut microbiota in hematologic cancer. (2023/08/25) ♡
- Acute Abdominal Pain as the Initial Presentation of an Acquired C1 Inhibitor Deficiency. (2023/08/16) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The role of proteasomes in tumorigenesis. (2023/08/06) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. REFRACTORY GUILLAIN-BARRÉ SYNDROME IN A PATIENT WITH ASYMPTOMATIC MULTIPLE MYELOMA SUCCESSFULLY TREATED WITH LOW-DOSE RITUXIMAB. (2023/08/01) ♡
- Simultaneous quantitation of multiple myeloma related dietary metabolites in serum using HILIC-LC-MS/MS. (2023/07/28) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. The Global Prevalence of Vitamin D Deficiency and Insufficiency in Patients with Multiple Myeloma: A Systematic Review and Meta-Analysis. (2023/07/20) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Perifoveal exudative vascular anomalous complex (PEVAC) resembling lesion in a patient with multiple myeloma. (2023/07/16) ♡
- Associations between an obesity-related dietary pattern and incidence of overall and site-specific cancers: a prospective cohort study. (2023/07/10) ♡
- Efficacy and Safety Analysis of VRD-PDCE in Treatment-Native Patients with Multiple Extramedullary Plasmacytomas or Plasma Cell Leukemia. (2023/07/01) ♡
- Incidence of antiresorptive agent-related osteonecrosis of the jaw: A multicenter retrospective epidemiological study in Hyogo Prefecture, Japan. (2023/07/01) ♡
- A prospective cohort study of infertility and cancer incidence. (2023/07/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Belantamab mafodotin in multiple myeloma. (2023/07/01) ♡
- Modifiable lifestyle risk factors and survival after diagnosis with multiple myeloma. (2023/07/01) ♡
- Blood components utilization in hematopoietic stem cell transplantation: Thirteen-year analysis from an apex oncology center of India. (2023/07/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. A gene signature can predict risk of MGUS progressing to multiple myeloma. (2023/06/29) ♡
- Autophagy-related genes affect the survival of multiple myeloma patients depending on chromosomal abnormality. (2023/06/16) ♡
- [Experimental Study on the Mechanism of Mangiferin Inhibiting Malignant Biological Characteristics of Multiple Myeloma and Exerting Anticancer Effect]. (2023/06/01) ♡
- The effects of nutritional support on cellular immunity of the patient with multiple myeloma undergoing chemotherapy. (2023/06/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. VEXAS syndrome: A review of bone marrow aspirate and biopsies reporting myeloid and erythroid precursor vacuolation. (2023/06/01) ♡
- Patient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation in Multiple Myeloma. (2023/06/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.